Quantitative analysis of the anti-VEGF effect for retinal capillary hemangiomas and vasoproliferative tumors
- 19 September 2025
- journal article
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (2) , 312-320
Abstract
Purpose: To assess the effect of anti-VEGF intravitreal injection (IVI) on vascularity and size of retinal angiomas using quantitative analysis of color fundus images. Methods: Color fundus images of retinal angiomas underwent RGB analysis with ImageJ software. White intensity (mean RGB values) and red ratio (red value/sum of green and blue values) were calibrated to obtain the white intensity and red indices, respectively. The lesion-disc area ratio was assessed for size changes. Results: Seventeen image sets of 10 angiomatous lesions were analyzed: 6 retinal hemangiomas from 4 eyes (4 patients) with Von Hippel–Lindau disease (VHL) and 4 retinal vasoproliferative tumors (VPT) from 4 eyes (4 patients). Overall, the white intensity index increased from 1.34 to 1.5 ( P = 0.001), and the red index decreased from 1.14 to 0.85 ( P < 0.001) post-IVI. In the VHL group, white intensity increased from 1.41 to 1.58 ( P = 0.013), and the red index decreased from 1.04 to 0.84 ( P < 0.001). In the VPT group, white intensity increased from 1.17 to 1.36 ( P = 0.031) and red index decreased from 1.39 to 0.87 ( P = 0.156) after IVI. Lesion-disc area ratio decreased significantly in both groups. Conclusion: Anti-VEGF induces whitening and reduces the red component of angiomas, diminishing vascularity and facilitating subsequent invasive treatments.Keywords
This publication has 26 references indexed in Scilit:
- 3-D OCT angiographic evidence of Anti-VEGF therapeutic effects on retinal capillary hemangiomaAmerican Journal of Ophthalmology Case Reports, 2022
- Retinal Vasoproliferative Tumors in 6 Patients With Neurofibromatosis Type 1JAMA Ophthalmology, 2014
- Reactive Retinal Astrocytic Tumors (So-called Vasoproliferative Tumors): Histopathologic, Immunohistochemical, and Genetic Studies of Four CasesAmerican Journal of Ophthalmology, 2013
- Reactive Retinal Astrocytic Tumors (So-called Vasoproliferative Tumors): Histopathologic, Immunohistochemical, and Genetic Studies of Four CasesAmerican Journal of Ophthalmology, 2013
- Retinal Vasoproliferative TumorsJAMA Ophthalmology, 2013
- Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangiomaInternational Ophthalmology, 2012
- Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau DiseaseOphthalmology, 2008
- Molecular Pathology and CXCR4 Expression in Surgically Excised Retinal Hemangioblastomas Associated with von Hippel–Lindau DiseaseOphthalmology, 2007
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyOphthalmology, 2006
- VHL Gene Deletion and Enhanced VEGF Gene Expression Detected in the Stromal Cells of Retinal AngiomaArchives of Ophthalmology (1950), 1999